Steroid Receptors in Breast Cancer
- 1 February 1982
- journal article
- clinical applications-of-therapeutic-advances
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 142 (2) , 363-366
- https://doi.org/10.1001/archinte.1982.00340150163026
Abstract
• Management of carcinomas of unknown primary site (CUPS) is determined by tumor histologic characteristics and clinical presentation. Undifferentiated carcinoma or adenocarcinomas comprise the majority of these tumors with typical occult primary sites in the pancreas, lung, liver, or gastrointestinal tract. Elaborate diagnostic evaluations are of little benefit to these patients because of low-yield, misleading results and lack of impact on treatment. Squamous carcinomas usually represent lymphatic metastases of head and neck tumors, which may be controlled for extended periods by irradiation. Unusual presentations of CUPS in which the histologic condition is adenocarcinoma or undifferentiated carcinoma are important to recognize because of the potential for specific therapy or cure of such entities as breast cancer and germ cell tumors. (Arch Intern Med 1982;142:357-359)This publication has 5 references indexed in Scilit:
- In pursuit of the unknown primaryThe American Journal of Surgery, 1978
- Cervical Metastases from an Unknown Primary TumorRadiology, 1974
- Breast carcinoma presenting as an axillary massThe American Journal of Surgery, 1971
- Metastatic carcinoma in cervical nodes with an unknown primary lesionThe American Journal of Surgery, 1966
- THE MANAGEMENT OF METASTASES IN LYMPH NODES WHEN THE PRIMARY TUMOR CANNOT BE FOUNDPlastic and Reconstructive Surgery, 1959